Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

ETRM

Enteromedics (ETRM)

Enteromedics
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ETRM
DatumZeitQuelleÜberschriftSymbolFirma
23/10/201722h32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ETRMEnteromedics
23/10/201714h30PR Newswire (US)EnteroMedics Announces Name Change to ReShape Lifesciences Inc. (NASDAQ: RSLS)NASDAQ:ETRMEnteromedics
17/10/201722h15Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:ETRMEnteromedics
16/10/201714h00PR Newswire (US)EnteroMedics Announces Presentations at ObesityWeek 2017NASDAQ:ETRMEnteromedics
13/10/201700h11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETRMEnteromedics
13/10/201700h05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETRMEnteromedics
13/10/201700h01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETRMEnteromedics
12/10/201722h52Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ETRMEnteromedics
12/10/201722h46PR Newswire (US)EnteroMedics Announces New Employee Inducement Option GrantsNASDAQ:ETRMEnteromedics
06/10/201715h04Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ETRMEnteromedics
03/10/201714h48Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ETRMEnteromedics
03/10/201714h47Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ETRMEnteromedics
03/10/201714h30PR Newswire (US)EnteroMedics Announces Acquisition Of ReShape MedicalNASDAQ:ETRMEnteromedics
12/09/201714h30PR Newswire (US)EnteroMedics to Present at the Ladenburg Thalmann 2017 Healthcare ConferenceNASDAQ:ETRMEnteromedics
05/09/201722h15PR Newswire (US)EnteroMedics Begins Post-Approval Study for the Treatment of Obesity with vBloc TherapyNASDAQ:ETRMEnteromedics
28/08/201722h05PR Newswire (US)Study Concludes Vagal Nerve Blocking with EnteroMedics' vBloc Therapy is Cost-EffectiveNASDAQ:ETRMEnteromedics
24/08/201723h02Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:ETRMEnteromedics
21/08/201715h00PR Newswire (US)EnteroMedics Announces First Veterans Choice Program vBloc® Implant at MedStar Health in MarylandNASDAQ:ETRMEnteromedics
16/08/201723h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ETRMEnteromedics
16/08/201715h00PR Newswire (US)EnteroMedics Announces Presentations Highlighting vBloc and Gastric Vest at IFSO Annual ConferenceNASDAQ:ETRMEnteromedics
15/08/201722h10Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ETRMEnteromedics
11/08/201722h15Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ETRMEnteromedics
11/08/201714h20PR Newswire (US)EnteroMedics Announces Pricing of $20 Million Underwritten Public OfferingNASDAQ:ETRMEnteromedics
11/08/201714h12Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ETRMEnteromedics
10/08/201722h34Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ETRMEnteromedics
10/08/201722h34PR Newswire (US)EnteroMedics Announces Proposed Underwritten Public OfferingNASDAQ:ETRMEnteromedics
08/08/201722h08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ETRMEnteromedics
08/08/201714h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ETRMEnteromedics
08/08/201713h00PR Newswire (US)EnteroMedics Announces Second Quarter 2017 Financial ResultsNASDAQ:ETRMEnteromedics
02/08/201713h00PR Newswire (US)EnteroMedics To Discuss Business Strategy And Financial Results For The Second Quarter Of 2017NASDAQ:ETRMEnteromedics
 Showing the most relevant articles for your search:NASDAQ:ETRM